Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-01-30

Clinical Trial Update: A Pilot Study to Investigate Fenoldopam Usage in the Prevention of Postoperative Renal Dysfunction in Patients at a High Risk for Renal Impairment During Cariopulmonary Bypass for Cardiac Surgery [Phase 2]

View source ↗

Summary

A Phase 2 pilot trial evaluated whether fenoldopam can prevent postoperative renal dysfunction in high-risk cardiac surgery patients undergoing cardiopulmonary …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Corlopam (fenoldopam mesylate)

Snippet

Sponsor: Summa Health System | Conditions: Cardiac Surgery With Cardiopulmonary Bypass | Phase 2 | Status: COMPLETED